Natalie A. Hawryluk, Ph.D. - Publications

2001 Brandeis University, Waltham, MA, United States 
synthetic organic chemistry

10/13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Letavic MA, Lord B, Bischoff F, Hawryluk NA, Pieters S, Rech JC, Sales Z, Velter AI, Ao H, Bonaventure P, Contreras V, Jiang X, Morton KL, Scott B, Wang Q, et al. Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists. Acs Medicinal Chemistry Letters. 4: 419-22. PMID 24900687 DOI: 10.1021/ml400040v  1
2010 Hawryluk NA, Merit JE, Lebsack AD, Branstetter BJ, Hack MD, Swanson N, Ao H, Maher MP, Bhattacharya A, Wang Q, Freedman JM, Scott BP, Wickenden AD, Chaplan SR, Breitenbucher JG. Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 7137-41. PMID 20947352 DOI: 10.1016/j.bmcl.2010.09.023  1
2010 Lebsack AD, Rech JC, Branstetter BJ, Hawryluk NA, Merit JE, Allison B, Rynberg R, Buma J, Rizzolio M, Swanson N, Ao H, Maher MP, Herrmann M, Freedman J, Scott BP, et al. 1,2-diamino-ethane-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepines as TRPV1 antagonists with improved properties. Bioorganic & Medicinal Chemistry Letters. 20: 7142-6. PMID 20932750 DOI: 10.1016/j.bmcl.2010.09.006  1
2004 Lou Y, Horikawa M, Kloster RA, Hawryluk NA, Corey EJ. A new chiral Rh(II) catalyst for enantioselective [2 + 1]-cycloaddition. mechanistic implications and applications. Journal of the American Chemical Society. 126: 8916-8. PMID 15264821 DOI: 10.1021/Ja047064K  1
2003 Shi B, Hawryluk NA, Snider BB. Formal synthesis of (+/-)-guanacastepene A. The Journal of Organic Chemistry. 68: 1030-42. PMID 12558432 DOI: 10.1021/Jo026702J  1
2002 Eggler JF, Gabel CA, Zandi K, Weaver JD, McKechney H, Dombroski MA, Peurano H, Hawryluk N. Synthesis of covalent [14C]-labeled diarylsulfonylurea (DASU) inhibitors of the processing and release of IL-1 Journal of Labelled Compounds and Radiopharmaceuticals. 45: 785-794. DOI: 10.1002/jlcr.602  1
2001 Corbin PS, Zimmerman SC, Thiessen PA, Hawryluk NA, Murray TJ. Complexation-induced unfolding of heterocyclic ureas. Simple foldamers equilibrate with multiply hydrogen-bonded sheetlike structures. Journal of the American Chemical Society. 123: 10475-88. PMID 11673978 DOI: 10.1021/Ja010638Q  1
2001 Snider BB, Hawryluk NA. Synthesis of the hydroazulene ring system of guanacastepene. Organic Letters. 3: 569-72. PMID 11178827 DOI: 10.1021/Ol0069756  1
2000 Hawryluk NA, Snider BB. Alcohol inversion using cesium carboxylates and DMAP in toluene. The Journal of Organic Chemistry. 65: 8379-80. PMID 11101401 DOI: 10.1021/Jo0007783  1
2000 Snider BB, Hawryluk NA. Synthesis of (-)-dysiherbaine. Organic Letters. 2: 635-8. PMID 10814397 DOI: 10.1021/Ol991393D  1
Low-probability matches
2020 Hawryluk NA. Macrofilaricides: An Unmet Medical Need for Filarial Diseases. Acs Infectious Diseases. PMID 32091199 DOI: 10.1021/acsinfecdis.9b00469  0.01
2010 Snider BB, Hawryluk NA. ChemInform Abstract: Synthesis of (-)-Dysiherbaine. Cheminform. 31: no-no. DOI: 10.1002/CHIN.200025248  0.01
2010 Hawryluk NA, Carruthers NI. 2-Pyridinylpiperazine Carboxamide Class and Related TRPV1 Antagonists Vanilloid Receptor Trpv1 in Drug Discovery: Targeting Pain and Other Pathological Disorders. 311-324. DOI: 10.1002/9780470588284.ch12  0.01
Hide low-probability matches.